carbamates has been researched along with Fabry Disease in 1 studies
Fabry Disease: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashe, KM | 1 |
| Budman, E | 1 |
| Bangari, DS | 1 |
| Siegel, CS | 1 |
| Nietupski, JB | 1 |
| Wang, B | 1 |
| Desnick, RJ | 1 |
| Scheule, RK | 1 |
| Leonard, JP | 1 |
| Cheng, SH | 1 |
| Marshall, J | 1 |
1 other study available for carbamates and Fabry Disease
| Article | Year |
|---|---|
Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease.
Topics: alpha-Galactosidase; Animals; Blood-Brain Barrier; Carbamates; Disease Models, Animal; Fabry Disease | 2015 |